{"id":"W3000919557","doi":"10.1200/jop.19.00421","title":"Application of the ASCO Value Framework and ESMO Magnitude of Clinical Benefit Scale to Assess the Value of Abiraterone and Enzalutamide in Advanced Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Enzalutamide; Medicine; Abiraterone; Prostate cancer; Clinical trial; Oncology; Internal medicine; Cancer; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001055476,0.0001013485,0.0004599463,0.00003520632,0.00004268841,0.000004977344,0.0001319605,0.0001496731,0.000008179355],"category_scores_gemma":[0.001635484,0.00005907613,0.00003960557,0.0003350722,0.0003497826,0.0001123742,0.0001779689,0.0004914445,0.000001235927],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006436084,"about_ca_system_score_gemma":0.0003414892,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004938116,"about_ca_topic_score_gemma":0.0001288455,"domain_scores_codex":[0.9984385,0.0003656945,0.0005195995,0.0002717117,0.0002424458,0.0001620014],"domain_scores_gemma":[0.9969878,0.001988747,0.0004211898,0.0002591058,0.0002424455,0.0001007184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009296794,0.0008225294,0.8401074,0.0004661579,0.0002356432,0.00001165972,0.004906554,0.0004841109,0.02534182,0.00148772,0.00009663572,0.116743],"study_design_scores_gemma":[0.00387723,0.002127866,0.9621981,0.0002256414,0.00033994,0.00001343159,0.001679546,0.0006683677,0.01923742,0.0006172799,0.0089318,0.0000833177],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9458441,0.00123566,0.0001318999,0.05088944,0.00007283071,0.001372732,0.00002070463,0.000005717391,0.0004269385],"genre_scores_gemma":[0.9885848,0.002538978,0.006385189,0.00218257,0.00006002145,0.0001709316,0.000002740933,0.00001285522,0.00006198252],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1220908,"threshold_uncertainty_score":0.2409055,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0653993345987498,"score_gpt":0.4721282607479003,"score_spread":0.4067289261491505,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}